Literature DB >> 20966685

Evaluation of parametrial spread in endometrial carcinoma.

Yoh Watanabe1, Takao Satou, Hidekatsu Nakai, Tomomaro Etoh, Kensaku Dote, Nahoko Fujinami, Hiroshi Hoshiai.   

Abstract

OBJECTIVE: To evaluate the detailed clinicopathologic characteristics of parametrial spread in uterine endometrial cancer.
METHODS: We retrospectively identified 334 individuals with uterine endometrial cancer who had undergone radical hysterectomy between 1988 and 2007. Parametrial spread was determined by histopathological analysis of surgically resected specimens.
RESULTS: Twenty-eight (8.4%) individuals had histopathologically confirmed parametrial spread, and lymphatic or blood vessel invasion (22 cases) was the most frequently observed type of parametrial spread; direct invasion to parametrial connective tissue (five cases) or cardinal lymph node metastasis (four cases) were less frequently observed. Parametrial spread occurred not only in individuals with cervical involvement but also in individuals with more than half myometrial invasion, retroperitoneal (pelvic, paraaortic, or both), lymph node metastasis, ovarian metastasis, positive peritoneal cytology results, and lymphovascular space invasion. Twenty-six individuals (92.9%) with parametrial spread showed more than one of these histopathological factors (median number of factors 3, range 1-6); the other two individuals had lymphovascular space invasion alone. In 10 individuals with parametrial spread (35.7%), the condition recurred during the median follow-up period of 49 months, and initial recurrence was observed in the lung in six individuals (60.0%). Although the long-term prognosis for those with parametrial spread was significantly poorer than that of those without parametrial spread, both among all individuals (P<.001) and among individuals with International Federation of Gynecology and Obstetrics stage III (P<.05), multivariate analysis showed that parametrial spread was not an independent prognostic factor for uterine endometrial cancer.
CONCLUSION: Parametrial spread cannot be predicted by cervical involvement alone but may be predicted by various lymphovascular space invasion-related histopathologic factors. Further, parametrial spread may not be an independent prognostic factor in individuals with uterine endometrial cancer. LEVEL OF EVIDENCE: III.

Entities:  

Mesh:

Year:  2010        PMID: 20966685     DOI: 10.1097/AOG.0b013e3181f80a49

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  6 in total

Review 1.  Current Issues in the Diagnosis and Treatment of Endometrial Carcinoma.

Authors:  J Stubert; B Gerber
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-02       Impact factor: 2.915

2.  CGB and GNRH1 expression analysis as a method of tumor cells metastatic spread detection in patients with gynecological malignances.

Authors:  Mirosław Andrusiewicz; Anna Szczerba; Maria Wołuń-Cholewa; Wojciech Warchoł; Ewa Nowak-Markwitz; Emilia Gąsiorowska; Krystyna Adamska; Anna Jankowska
Journal:  J Transl Med       Date:  2011-08-09       Impact factor: 5.531

3.  What is the impact of radical hysterectomy on endometrial cancer with cervical involvement?

Authors:  Salim Abraham Barquet-Muñoz; David Cantú-de-León; Antonio Bandala-Jacques; Aarón González-Enciso; David Isla-Ortiz; Diddier Prada; Luis A Herrera; R A Salcedo-Hernández
Journal:  World J Surg Oncol       Date:  2020-05-21       Impact factor: 2.754

4.  Survival and recurrence in stage II endometrial cancers in relation to uterine risk stratification after introduction of lymph node resection and omission of postoperative radiotherapy: a Danish Gynecological Cancer Group Study.

Authors:  Gitte Ørtoft; Claus Høgdall; Estrid S Hansen; Margit Dueholm
Journal:  J Gynecol Oncol       Date:  2019-10-04       Impact factor: 4.401

5.  Significance of lymphovascular space invasion in epithelial ovarian cancer.

Authors:  Koji Matsuo; Todd B Sheridan; Kiyoshi Yoshino; Takahito Miyake; Karina E Hew; Dwight D Im; Neil B Rosenshein; Seiji Mabuchi; Takayuki Enomoto; Tadashi Kimura; Anil K Sood; Lynda D Roman
Journal:  Cancer Med       Date:  2012-09-14       Impact factor: 4.452

6.  ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up.

Authors:  Nicoletta Colombo; Carien Creutzberg; Frederic Amant; Tjalling Bosse; Antonio González-Martín; Jonathan Ledermann; Christian Marth; Remi Nout; Denis Querleu; Mansoor Raza Mirza; Cristiana Sessa
Journal:  Int J Gynecol Cancer       Date:  2016-01       Impact factor: 3.437

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.